483 related articles for article (PubMed ID: 30295165)
21. Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13.
Cruz JN; Costa JFS; Khayat AS; Kuca K; Barros CAL; Neto AMJC
J Biomol Struct Dyn; 2019 Apr; 37(6):1616-1627. PubMed ID: 29633908
[TBL] [Abstract][Full Text] [Related]
22. Hydroxamic acid derivatives as selective HDAC3 inhibitors: computer-aided drug design strategies.
Patel P; Shrivastava SK; Sharma P; Kurmi BD; Shirbhate E; Rajak H
J Biomol Struct Dyn; 2024; 42(1):362-383. PubMed ID: 36995068
[TBL] [Abstract][Full Text] [Related]
23. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
24. Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles.
Yu CX; Tan JW; Rullah K; Imran S; Tham CL
J Biomol Struct Dyn; 2023; 41(22):12978-12996. PubMed ID: 36709457
[TBL] [Abstract][Full Text] [Related]
25. Anticancer Perspectives on the Fungal-Derived Polyphenolic Hispolon.
Islam MT; Ali ES; Khan IN; Shaw S; Uddin SJ; Rouf R; Dev S; Saravi SSS; Das N; Tripathi S; Yele SU; Das AK; Shilpi JA; Mishra SK; Mubarak MS
Anticancer Agents Med Chem; 2020; 20(14):1636-1647. PubMed ID: 32560616
[TBL] [Abstract][Full Text] [Related]
26. Interaction of compounds derived from the Chinese medicinal formula Huangqi Guizhi Wuwu Tang with stroke-related numbness and weakness targets: An in-silico docking and molecular dynamics study.
Lee S; Wong AR; Yang AWH; Hung A
Comput Biol Med; 2022 Jul; 146():105568. PubMed ID: 35508083
[TBL] [Abstract][Full Text] [Related]
27. Binding mode analysis, dynamic simulation and binding free energy calculations of the MurF ligase from Acinetobacter baumannii.
Ahmad S; Raza S; Uddin R; Azam SS
J Mol Graph Model; 2017 Oct; 77():72-85. PubMed ID: 28843462
[TBL] [Abstract][Full Text] [Related]
28. Investigation of non-hydroxamate scaffolds against HDAC6 inhibition: A pharmacophore modeling, molecular docking, and molecular dynamics simulation approach.
Zeb A; Park C; Son M; Rampogu S; Alam SI; Park SJ; Lee KW
J Bioinform Comput Biol; 2018 Jun; 16(3):1840015. PubMed ID: 29945500
[TBL] [Abstract][Full Text] [Related]
29. Investigating the role of N-terminal domain in phosphodiesterase 4B-inhibition by molecular dynamics simulation.
Sharma V; Wakode S
J Biomol Struct Dyn; 2021 Aug; 39(12):4270-4278. PubMed ID: 32552529
[TBL] [Abstract][Full Text] [Related]
30. Anti-Inflammatory and Anti-Rheumatic Potential of Selective Plant Compounds by Targeting TLR-4/AP-1 Signaling: A Comprehensive Molecular Docking and Simulation Approaches.
Khan A; Khan SU; Khan A; Shal B; Rehman SU; Rehman SU; Htar TT; Khan S; Anwar S; Alafnan A; Rengasamy KR
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807562
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
[TBL] [Abstract][Full Text] [Related]
32. Virtual screening of flavonoids as potential RIPK1 inhibitors for neurodegeneration therapy.
Bepari AK; Shatabda S; Reza HM
PeerJ; 2024; 12():e16762. PubMed ID: 38274328
[TBL] [Abstract][Full Text] [Related]
33.
Akabli T; Toufik H; Lamchouri F
J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
[TBL] [Abstract][Full Text] [Related]
34. Molecular docking and simulation studies against nucleoside diphosphate kinase (NDK) of
Bagewadi ZK; Aakanksha UK; Yaraguppi DA; Yunus Khan TM; Deshpande SH; Dammalli M; Revankar AG; Savalagi AJ; Hiremath SV
J Biomol Struct Dyn; 2023; 41(22):12610-12619. PubMed ID: 36651083
[No Abstract] [Full Text] [Related]
35. In silico molecular docking and dynamic simulation of eugenol compounds against breast cancer.
Rasul HO; Aziz BK; Ghafour DD; Kivrak A
J Mol Model; 2021 Dec; 28(1):17. PubMed ID: 34962586
[TBL] [Abstract][Full Text] [Related]
36. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and in vitro cell-based evaluation of the anti-cancer activities of hispolon analogs.
Balaji NV; Ramani MV; Viana AG; Sanglard LP; White J; Mulabagal V; Lee C; Gana TJ; Egiebor NO; Subbaraju GV; Tiwari AK
Bioorg Med Chem; 2015 May; 23(9):2148-2158. PubMed ID: 25842364
[TBL] [Abstract][Full Text] [Related]
38. Molecular docking and molecular dynamics studies of bioactive compounds contained in noni fruit (
Lolok N; Sumiwi SA; Muhtadi A; Susilawati Y; Hendriani R; Ramadhan DSF; Levita J; Sahidin I
J Biomol Struct Dyn; 2022 Sep; 40(15):7091-7098. PubMed ID: 33682637
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
40. Effects of hispolon on glioblastoma cell growth.
Arcella A; Oliva MA; Sanchez M; Staffieri S; Esposito V; Giangaspero F; Cantore G
Environ Toxicol; 2017 Sep; 32(9):2113-2123. PubMed ID: 28618133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
